Rubio C A, Matthies M, Itabashi M, Hirota T
Department of Pathology, Karolinska Institute, Stockholm, Sweden.
Jpn J Cancer Res. 1996 Jul;87(7):711-7. doi: 10.1111/j.1349-7006.1996.tb00282.x.
The aim of this work was to investigate the extension of intestinal metaplasia (IM), as well as to quantitate various components of IM (namely sialomucins, sulfomucins and Paneth cells), in entire gastrectomy specimens from Swedish and Japanese patients. The length of the gastric mucosa was assessed by morphometry. The percent of sections with IM was regarded as the extension of IM in the specimens. Histochemically labeled sialomucins, sulfomucins and Paneth cells (the 3 main findings in gastric IM) were quantified in separate sections with the aid of an image analyzer. In total, 1,321 sections corresponding to 6 gastrectomy specimens were quantified. Sialomucins and sulfomucins were more extensively distributed in the 4 specimens with carcinoma than in the 2 without carcinoma (one having a peptic ulcer and the other, hereditary gastric cancer syndrome (HGCS) without carcinoma). On the other hand, quantitative analysis in Swedish specimens indicated that the highest values for sialomucins, sulfomucins and Paneth cells were present in HGCS. When Swedish and Japanese specimens with adenocarcinoma were compared, only sulfomucins (denoting Types II and III IM) were significantly higher in those carrying an intestinal-type carcinoma (ITC) than in those with diffuse-type carcinoma (DTC). The results substantiate those obtained with gastric biopsies by other authors. On the other hand, the mucosal extension and the amount of sulfomucins are not comparable parameters (since that mucin was not equally distributed, but "concentrated" in certain areas in the mucosa). One possible conclusion is that the focal distribution of acidic mucins and of Paneth cells in the gastric mucosa may strongly influence their detection rate in gastric biopsies. Thus, haphazard biopsy of the gastric mucosa may fail to sample areas with sulfomucins in population studies aiming to detect individuals at risk. Such sampling errors in gastric biopsies may explain the conflicting results on this subject appearing in the literature.
这项工作的目的是研究瑞典和日本患者全胃切除标本中肠化生(IM)的范围,并对IM的各种成分(即涎酸粘蛋白、硫酸粘蛋白和潘氏细胞)进行定量分析。通过形态计量学评估胃黏膜的长度。含有IM的切片百分比被视为标本中IM的范围。借助图像分析仪,在单独的切片中对经组织化学标记的涎酸粘蛋白、硫酸粘蛋白和潘氏细胞(胃IM的3个主要发现)进行定量分析。总共对相当于6个胃切除标本的1321个切片进行了定量分析。涎酸粘蛋白和硫酸粘蛋白在4个有癌的标本中比在2个无癌的标本中(一个有消化性溃疡,另一个是无癌的遗传性胃癌综合征(HGCS))分布更广泛。另一方面,瑞典标本的定量分析表明,HGCS中涎酸粘蛋白、硫酸粘蛋白和潘氏细胞的值最高。当比较患有腺癌的瑞典和日本标本时,只有硫酸粘蛋白(表示II型和III型IM)在肠型癌(ITC)患者中显著高于弥漫型癌(DTC)患者。这些结果证实了其他作者通过胃活检获得的结果。另一方面,黏膜范围和硫酸粘蛋白的量不是可比参数(因为粘蛋白分布不均,而是“集中”在黏膜的某些区域)。一个可能的结论是,胃黏膜中酸性粘蛋白和潘氏细胞的局灶性分布可能强烈影响它们在胃活检中的检出率。因此,在旨在检测高危个体的人群研究中,对胃黏膜进行随意活检可能无法采集到含有硫酸粘蛋白的区域。胃活检中的这种抽样误差可能解释了文献中关于该主题出现的相互矛盾的结果。